Finding causes of non-immune fluid buildup in babies
Part of Blood & lymphatic, Genetic & congenital, Immune system & allergy, Women’s health & pregnancy clinical trials.
This study looks for the underlying cause of “non-immune hydrops fetalis,” a serious condition where a baby has abnormal fluid buildup. It focuses on families whose usual genetic tests didn’t find an answer (or weren’t completed before birth).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant with a fetus diagnosed with non-immune hydrops fetalis and standard genetic tests were non-diagnostic
- OR your baby was diagnosed before birth, but genetic testing couldn’t be finished or was delayed until after delivery
- You are a biological parent of the fetus or baby with non-immune hydrops fetalis
- The fluid buildup is not from twin-to-twin transfusion syndrome
- The fluid buildup is not clearly caused by a viral infection
- The fluid buildup is not due to blood-type mixing problems (alloimmunization)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study offers genetic sequencing to find the cause of certain serious fetal problems, such as structural anomalies, severe growth restriction, or unexplained pregnancy loss after 14 weeks. It aims to help families understand why the issue occurred and guide future care.
This study tracks pregnancies affected by hemolytic disease of the fetus and newborn (HDFN). It collects information to better understand the condition and improve care. You may join if you are pregnant with a history of a prior affected pregnancy and have a current antibody that could harm your baby.
This study tests a new DNA-based method to determine a baby's blood type before birth, which helps doctors manage pregnancies at risk for hemolytic disease of the fetus and newborn (HDFN). It aims to improve care for mothers with blood type incompatibility.
This study looks at two substances in the blood from the umbilical cord (IL-6 and lactate) to see if they can help doctors understand how well a newborn is doing after birth.
This study uses advanced genetic testing (whole genome sequencing) on tissue samples from fetuses with structural abnormalities detected on ultrasound. The goal is to identify genetic causes of birth defects to help with diagnosis and understanding of your baby's condition.
This study looks at the genetic material in the fluid around the baby (amniotic fluid) and in the placenta to better understand complex heart defects in unborn babies. The goal is to find new clues that could help doctors care for these babies before and after birth.
Hear when a new Non-Immune Hydrops Fetalis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.